Another study focused on the diagnostic value of galectin-3 in inflammatory pancreatic disease and indicated that galectin-3 is not an interesting biomarker for the detection of pancreatic adenocarcinoma [23]. Here, LGALS3 is linked to pancreatic adenocarcinoma.